Seeking Alpha
  • MTF Investing
    $GALE finding support at $1.90. I know investors don't like dilution, but the company needed this to get Abstral and NeuVax going.
    9/13/13
    Reply (7)
    • jsnesser: they could have priced it higher and not effect the present shareholders will a loss.
      9/13/13
    • hbarns: PR release for the public offering was well timed. Hopefully there's some good news next week that pushes the price back up.
      9/13/13
    • dannick: You guys going to double down your bets on GALE @ 1.90?
      9/14/13
    • hbarns: Yes, done-but dont take that to mean I know anything special. Been following GALE and Ahn a while now and they stand out amongst bio-pharms.
      9/14/13
    • pwd9398: Increased my long position immediately following the secondary. IMO Abstral sales are going to pleasantly surprise
      9/24/13
    • MTF Investing: I increased mine yesterday. Should see a healthy bump in the next 3-6 months.
      9/25/13
    • dannick: I increased my hold at 1.96 and then it dropped down to 1.91. I know its only 4 cents but it really annoyed me I could have bought lower =P
      9/25/13